News

Moximed Welcomes Michael Mydra as Senior VP for Market Access

Moximed Welcomes Michael Mydra as Senior VP for Market Access

Moximed Welcomes Michael Mydra as Senior Vice President of Reimbursement

Moximed, a leader in innovative medical devices, has announced the addition of Michael Mydra to its team as the Senior Vice President of Reimbursement and Market Access. This appointment aims to reinforce the company’s commitment to enhancing care for individuals suffering from knee osteoarthritis (OA).

Michael Mydra's Expertise and Experience

Michael Mydra is recognized for his remarkable track record in achieving critical coding, coverage, and payment strategies for groundbreaking medical technologies. Chris Gleason, the President and CEO of Moximed, expressed enthusiasm about Michael joining the Moximed team, noting that his background in establishing five Category I CPT codes will be invaluable as the company seeks to broaden access to the MISHA Knee System.

Previous Roles Contributing to His Success

Before joining Moximed, Michael Mydra held a pivotal position as the Senior Vice President of Reimbursement and Market Access at PainTEQ, Inc. His extensive experience spans a variety of roles in reimbursement and market access across several well-regarded medical technology firms, including Sanarus Medical, Vertos Medical, SI-BONE, Boston Scientific, and Profound Medical.

A Vision for Expanding Access to Treatment

In reflecting on his new role, Michael expressed, "It is an honor to join the talented team at Moximed. The clinical evidence supporting the MISHA Knee System is robust and will continue to grow. I am eager to help expand access to this disruptive technology as we look to transform the lives of millions of people affected by knee osteoarthritis." His enthusiasm underscores the potential impact of Moximed’s advancements in OA treatment.

What is the MISHA Knee System?

The MISHA Knee System is designed specifically for patients suffering from medial knee OA who have not found relief through other treatments. Many of these individuals continue to endure significant pain, making daily activities cumbersome. This demographic often includes those who are not suitable for joint replacement surgery due to age or the absence of advanced OA. Total knee replacements are usually a last resort for patients with serious illness. Thus, the need for effective alternatives is paramount.

Understanding Osteoarthritis and Treatment Needs

Knee OA arises when the natural shock-absorbing structures of the joint—such as cartilage and meniscus—start failing. This deterioration results in chronic pain and limits individuals' daily activities. Many people dealing with mild to moderate OA are otherwise active and healthy, often unwilling to consider total knee replacement, which indicates advanced disease. Therefore, preserving knee function and facilitating a better quality of life remain high priorities for these patients.

How the MISHA Knee System Works

Research has shown that offloading painful osteoarthritic joints can alleviate discomfort and enhance function. The MISHA Knee System distinguishes itself as the first implantable shock absorber, designed to reduce stress on the knee joint with every step taken. This innovative approach allows users to experience pain relief and potentially postpone the need for more invasive procedures like joint replacement. Placed on the medial side of the knee, the system synchronizes with natural joint movements, diminishing peak forces on the knee by approximately 30% with each step.

Commitment to Quality and Safety

Moximed’s MISHA Knee System has received FDA clearance, affirming its safety and efficacy for users. This significant milestone highlights Moximed's dedication to advancing care standards for individuals suffering from knee OA through innovative solutions.

About Moximed

Headquartered in Fremont, California, Moximed’s innovative technology is the culmination of over ten years of clinical research and development. The MISHA Knee System represents the first implantable shock absorber targeting the treatment of medial compartment knee OA. Moximed is committed to improving the standard of care and enhancing the quality of life for millions of individuals battling knee pain associated with osteoarthritis.

Frequently Asked Questions

What role has Michael Mydra taken on at Moximed?

Michael Mydra has joined Moximed as Senior Vice President of Reimbursement and Market Access, focusing on expanding access to innovative treatments.

What is the MISHA Knee System designed for?

The MISHA Knee System is specifically developed for patients with medial knee OA who have not found relief through other treatments and who aren't ready for joint replacement.

How does the MISHA Knee System alleviate knee pain?

The MISHA Knee System acts as an implantable shock absorber, reducing weight on the knee joint with each step, thereby easing pain and improving function.

Is the MISHA Knee System FDA approved?

Yes, the MISHA Knee System has received FDA clearance, confirming its safety for patients with knee osteoarthritis.

Where is Moximed located?

Moximed is headquartered in Fremont, California, and is committed to advancing treatment options for knee osteoarthritis sufferers.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Loyalty Programs Cut $1500 Annually for Consumers

Updated Category News Views 132

Loyalty Programs: An Essential Tool for Households In a world where every dollar counts, retail loyalty programs have become more than just a marketing strategy—they're lifelines for American households scraping through each month. According to fresh research by the Retail Industry Leaders Association (RILA) and conducted by market research leader Circana, these...

Continue Reading
Zettia R. Barnes: Charting a Path in Home Healthcare

Updated Category News Views 146

The Lifeline of Home Healthcare in DeSoto You know, it ain't every day that someone like Zettia R. Barnes steps up in the realm of home healthcare and makes a mark that genuinely sticks. From rubbing shoulders with patients to steering a whole dang organization like Angels of Hands Home Health Agency Corp., she's got her hands full—and frankly, it’s folks like her who...

Continue Reading
Biotech Hit or Miss: Trials and Tribulations

Updated Category News Views 96

Biotech's Roller Coaster: Triumphs and Setbacks Ah, the biotech sector—it's a bit like jumping on a bull, ain't it? You barely hang on when the beast bucks. Monday's market action was downright wild. The S&P 500 didn't have a party, tumbling 1.92%, and the Nasdaq wasn't any friendlier, plummeting 2.49%. Yet, inside this storm, we see some biotech names either catching...

Continue Reading
Austin Rattler Event Revamps With Two-Day Off-Road Bash

Updated Category News Views 42

Austin's Off-Road Bash Kicks Up Dust in Hill Country It's not just another grind in the biking and running world; the Life Time Austin Rattler's gone off the reservation pushing the pedals and the pace across the rugged terrain of Texas Hill Country. Here's to muscles burning and soles slapping the dirt for two straight days, all in the name of challenging nature's best....

Continue Reading
Exploring Creation: A Fresh Look at Genesis

Updated Category News Views 67

Opening Up Genesis in a New Light Hey, if you’re like most folks, you’ve probably heard Genesis framed as the battleground for science versus religion debates, right? Enter into this mix a fresh take with Robert E. Franzen’s new book, The Narration of Creation. This book asks you to overlook those grand philosophical fights and instead focus on the narrative itself....

Continue Reading
Hermes AI: A New Era in Market Analysis?

Updated Category News Views 111

Revolution or Just Another App? In a world where stock market insights are as cryptic as hieroglyphs to the average Joe, here comes the Hermes AI Analyzer, breaking onto the scene and promising to translate Wall Street's complex lingo into plain, simple language. It's the brainchild of Turkish engineer Umut Tugrul, who has spent decades in the trenches of software...

Continue Reading
Giovanni Recalde Sues County After False Report

Updated Category News Views 153

Justice and Reputation: A Mix-Up Costs Big When the cops screw up, sometimes they really take the cake. That's what Giovanni Recalde learned, the hard way, when his name got tangled in a mess related to a gambling operation he wasn't even a part of. Prince William County police pasted his name into their daily incident report last year like it was no big deal. But it...

Continue Reading
Rakuten Medical Fires Up Phase 1 Trial for RM-0256 Therapy

Updated Category News Views 219

Taking Aim at Refractory Tumors in Japan Get this—Rakuten Medical is stepping into the ring with their new cancer-busting tactic, RM-0256 photoimmunotherapy, right in Japan. We're talking about a Phase 1 trial that'll throw a new kind of punch at solid tumors, specifically targeting troublesome skin cancers that don’t seem to play nice with current treatments. Now,...

Continue Reading
Mars Moves on Cash Tender Offers for Seniors' Notes

Updated Category News Views 197

A Strategic Financial Maneuver or a Casual Gambit? Okay, what’s Mars up to now, you ask? Here we go with this. The behemoth behind some of your favorite snacks and pet indulgences is making waves—not with candy, but with cash. Mars, Incorporated is rolling out tender offers to buy back a substantial chunk of its Senior Notes for $2 billion in cold, hard cash. When a...

Continue Reading
Main Capital Partners Backs TaskRay: Salesforce Expansion

Updated Category News Views 118

Investing in Transformation Main Capital Partners has thrown in with TaskRay, joining hands with Cloud Coach and JustOn to shake up customer delivery on Salesforce. These three are cooking up an ambitious AI-driven platform that's gunning to streamline from project management to financial operations. Main's stepping into this mix with a mindset that aligns with over 800...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Organizations: RockDove Solutions on Crisis Communication

Updated Category News Views 111

Understanding the Importance of Crisis Communication Plans In today's fast-paced world, effective crisis communication is more critical than ever for businesses. Surprisingly, fewer than half of U.S. companies have formal crisis communication strategies in place. This statistic highlights a significant gap in business continuity planning, where communication often...

Continue Reading
Hafnia Limited Reports Strong Earnings for Q3 2024 Period

Updated Category News Views 83

Hafnia Limited Reports Strong Earnings for Q3 2024 Period Hafnia Limited (“Hafnia” or “the Company”, OSE ticker code: “HAFNI”, NYSE ticker code: “HAFN”), a premier product tanker company with an extensive and modern fleet exceeding 130 vessels, has recently reported promising financial results for the three and nine months ended September 30, 2024. Key...

Continue Reading
Recent Shareholding Changes at Irish Continental Group PLC

Updated Category News Views 138

Understanding Director and PDMR Shareholding Notifications In the world of corporate governance, transparency plays a crucial role in maintaining trust, particularly when it comes to senior management and directors. Recent notifications reveal key transactions involving persons discharging managerial responsibilities (PDMRs) at Irish Continental Group plc. Overview of...

Continue Reading
Experience the Summer Vibes at Coastal Mississippi Events

Updated Category News Views 220

Summer Events in Coastal Mississippi Come Play Coastal all summer long with seafood feasts, fireworks, car shows, and more! Ready to turn up the fun this summer? Coastal Mississippi is bringing a thrilling lineup of unforgettable events, all set against the backdrop of 62 miles of beautiful shoreline. From fresh seafood to electrifying fireworks, sensational car shows,...

Continue Reading
GUNNAR Optiks and 2K Games Unveil Exciting New Glasses

Updated Category News Views 197

GUNNAR Optiks Partners with 2K Games for New Glasses GUNNAR Optiks, a frontrunner in combating digital eye strain and a pioneer in blue light blocking eyewear, has teamed up with 2K Games to introduce an exciting new collection inspired by the much-anticipated Borderlands 4. This striking collection unveils its first eyewear style, aptly named the Ripper, marking the...

Continue Reading